Month 2018
Facile Synthesis of 2,3-Dihydroxyquinoxaline and 2,3-Dichloroquinoxaline
Derivatives
2,3-Dichloro-6-cyanoquinoxaline (3g). White solid, mp
235–237°C; (lit. [20] 239°C), IR (KBr, ν, cmꢀ1): 3072,
3043 (CH¼CH), 2231 (CN), 1552, 1541 (CH¼CH),
1383,1295, 1281, 1260, 1179, 1168, 1125, 1027, 1005,
912, 856, 622, 562, 435; H NMR (600 MHz, CDCl3) (δ,
ppm): 7.99 (dd, J = 8.7, 1.8 Hz, 1H, Ar-H), 8.17 (dd,
(CH¼CH), 1619 (CH¼CH), 1488, 1467 (CH¼CH),
1401, 1300, 1263, 1216, 1184, 1145, 1122, 1021, 998,
833, 622, 540, 444; 1H NMR (600 MHz, CDCl3) (δ,
ppm): 3.96 (s, 3H, OCH3), 7.30 (d, J = 2.7 Hz, 1H,
Ar-H), 7.43 (dd, J = 9.2, 2.7 Hz, 1H, Ar-H), 7.90 (d,
J = 9.2 Hz, 1H, Ar-H); 13C NMR (150 MHz, CDCl3) (δ,
ppm): 55.9, 105.8, 124.2, 129.0, 136.5, 142.3, 142.3,
1
J = 8.7, 0.4 Hz, 1H, Ar-H), 8.42 (dd, J = 1.7, 0.4 Hz,
1H, Ar-H); EI–MS: m/z 223 [M]+.
145.5, 161.7; ESI–MS: m/z 229.0 [M+H]+.
2,3-Dichloro-6-methylquinoxaline (3h). White solid, mp
2,3-Dichlorobenzo[g]quinoxaline (3n). Yellow solid, mp
112–114°C; (lit. [20] 113–114°C), IR (KBr, ν, cmꢀ1):
3065, 3031 (CH¼CH), 1620, 1566 (CH¼CH), 1526,
1492 (CH¼CH), 1295, 1271, 1257, 1185, 1154, 1127,
996, 619, 574, 438; 1H NMR (600 MHz, CDCl3) (δ,
ppm): 2.60 (s, 3H, CH3), 7.63 (d, J = 8.6 Hz, 1H, Ar-H),
7.78 (s, 1H, Ar-H), 7.90 (d, J = 8.5 Hz, 1H, Ar-H); 13C
NMR (150 MHz, CDCl3) (δ, ppm): 21.8, 127.0, 127.6,
133.4, 139.0, 140.6, 142.1, 144.2, 145.1; EI–MS: m/z
212 [M]+.
236–238°C; IR (KBr, ν, cmꢀ1): 1557 (CH¼CH), 1302,
1200, 1155, 1109, 998, 886, 748, 537, 497, 470; 1H
NMR (500 MHz, CDCl3) (δ, ppm): 7.53–7.75 (m, 2H,
Ar-H), 8.04–8.24 (m, 2H, Ar-H), 8.60 (s, 2H, Ar-H); 13C
NMR (125 MHz, CDCl3) (δ, ppm): 126.9, 127.7, 128.5,
134.2, 137.0, 145.1; EI–MS: m/z 248 [M]+.
Acknowledgments. We appreciate the financial support from the
National Natural Science Foundation of China (no. 21701018)
and the Fundamental and Advanced Research Projects of
Chongqing City (no. cstc2017jcyjAX0228).
2,3,6,7-Tetrachloroquinoxaline (3i).
White solid, mp
168–170°C; (lit. [23] 165–168°C), IR (KBr, ν, cmꢀ1):
3078 (CH¼CH), 1773, 1586 (CH¼CH), 1539, 1520,
1451 (CH¼CH), 1398, 1262, 1152, 1100, 1009, 975,
892, 571, 529, 439; 1H NMR (600 MHz, CDCl3) (δ,
ppm): 8.12 (s, 2H, Ar-H); 13C NMR (150 MHz,
CDCl3) (δ, ppm): 128.7, 136.1, 139.1, 146.7; EI–MS: m/z
266 [M]+.
REFERENCES AND NOTES
[1] Ajani, O. O. Eur J Med Chem 2014, 85, 688.
[2] Achelle, S.; Baudequin, C.; Plé, N. Dyes Pigments 2013, 98,
575.
[3] Pereira, J. A.; Pessoa, A. M.; Cordeiro, M. N. D. S.;
Fernandes, R.; Prudencio, C.; Noronha, J. P.; Vieira, M. Eur J Med Chem
2015, 97, 664.
[4] Yang, Y.; Zhang, S.; Wu, B.; Ma, M.; Chen, X.; Qin, X.; He,
M.; Hussain, S.; Jing, C.; Ma, B.; Zhu, C. Chem Med Chem 2012, 7, 823.
[5] Lee, S. H.; Kim, N.; Kim, S. J.; Song, J.; Gong, Y. D.; Kim, S.
Y. J Cancer Res Clin 2013, 139, 1279.
[6] Xia, Q. H.; Hu, W.; Chen, L.; Wu, J. F.; Yang, L.; Han, X. M.;
Shen, Y. M.; Li, Z. Y.; Li, X. Eur J Med Chem 2016, 124, 311.
[7] Bouanane, Z.; Bounekhel, M.; Elkolli, M.; Abrigach, F.;
Khoutoul, M.; Bouyala, R.; Touzani, R.; Hellal, A. J Mol Struct 2017,
1139, 238.
[8] Sekhar, K. V. G. C.; Rao, V. S.; Deuther-Conrad, W.; Sridhar,
D.; Nagesh, H. N.; Kumar, V. S.; Brust, P.; Kumar, M. M. K. Med Chem
Res 2013, 22, 1660.
[9] Nakhi, A.; Rahman, M. S.; Kishore, R.; Meda, C. L.; Deora, G.
S.; Parsa, K. V. L.; Pala, M. Bioorg Med Chem Lett 2012, 22, 6433.
[10] Kotra, V.; Pradeep, K.; Vasanthi, R. Der Pharm Chem 2013, 5,
301.
[11] Engelhart, J. U.; Lindner, B. D.; Tverskoy, O.; Schaffroth, M.;
Rominger, F.; Bunz, U. H. W. J Org Chem 2013, 78, 1249.
[12] Cho, W.; Cho, H.; Lee, C. S.; Lee, B. Y.; Moon, B. J.; Kang, J.
H. Organometallics 2014, 33, 1617.
[13] Madrzak-Litwa; Iwona; Borowiak-Resterna; Aleksandra
Heterocycl Commu 2014, 20, 177.
2,3,6-Trichloro-7-fluoroquinoxaline (3j).
White solid,
mp 155–157°C; IR (KBr, ν, cmꢀ1): 3092, 3041
(CH¼CH), 1777, 1610, 1552 (CH¼CH), 1526, 1477,
1426 (CH¼CH), 1362, 1264, 1236, 1207, 1133, 1011,
1
896, 754, 603, 560, 448; H NMR (600 MHz, CDCl3) (δ,
ppm): 7.76 (d, J = 8.7 Hz, 1H, Ar-H), 8.12 (d,
J = 7.4 Hz, 1H, Ar-H); 13C NMR (150 MHz, CDCl3) (δ,
ppm): 113.2, 127.2, 129.4, 137.5, 139.9,145.9,
146.7,157.9,159.6; EI–MS: m/z 250 [M]+.
2,3-Dichloro-5-methylquinoxaline (3k). White solid, mp
88–90°C; IR (KBr, ν, cmꢀ1): 3050, 3013 (CH¼CH),
1602, 1569, 1528 (CH¼CH), 1471 (CH¼CH), 1378,
1270, 1184, 1142, 1073, 984, 942, 809, 773, 516, 444;
1H NMR (150 MHz, CDCl3) (δ, ppm): 2.75 (s, 3H,
CH3), 7.63 (d, J = 7.1 Hz, 1H, Ar-H), 7.68 (t, J = 7.7 Hz,
1H, Ar-H), 7.88–7.71 (m, 1H, Ar-H); 13C NMR
(150 MHz, CDCl3) (δ, ppm): 17.1, 125.9, 130.9, 131.1,
137.1, 139.9, 140.8, 144.0, 144.9; EI–MS: m/z 212 [M]+.
2,3-Dichloro-6,7-dimethylquinoxaline (3l).
White solid,
mp 178–180°C; IR (KBr, ν, cmꢀ1): 2950 (CH¼CH),
1623, 1547 (CH¼CH), 1519, 1485 (CH¼CH), 1442,
1388, 1260, 1202, 1133, 1022, 988, 877, 861, 575, 442;
1H NMR (150 MHz, CDCl3) (δ, ppm): 2.49 (s, 6H, CH3,
CH3), 7.75 (s, 2H, Ar-H); 13C NMR (150 MHz, CDCl3)
(δ, ppm): 20.4, 127.1, 139.5,142.1, 144.1; ESI–MS: m/z
227.0 [M+H]+.
[14] Li, N.; Yang, F.; Stock, H. A.; Dearden, D. V.; Lamb, J. D.;
Harrison, R. G. Org Biomol Chem 2012, 10, 7392.
[15] Mota, F.; Gane, P.; Hampden-Smith, K.; Allerston, C. K.;
Garthwaite, J.; Selwood, D. L. Bioorg Med Chem 2015, 23, 5303.
[16] Miranda, F. D. S.; Signori, A. M.; Vicente, J.; Souza, B. D.;
Priebe, J. P.; Szpoganicz, B.; Sanches, N.; AdemirNeves, G. Tetrahedron
2008, 64, 5410.
[17] Taniguchi, T.; Dennis, P. Curran Org Lett 2012, 14, 4540.
[18] Molander, G. A.; Cavalcanti, L. N.; Canturk, B.; Pan, P. S.;
Kennedy, L. E. J Org Chem 2009, 74, 7364.
2,3-Dichloro-6-methoxylquinoxaline (3m).
White solid,
mp 154–156°C; IR (KBr, ν, cmꢀ1): 3067, 3013
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet